CY1110620T1 - Μεθοδος θεραπειας οξειας παραρρινοκολπιτιδας - Google Patents
Μεθοδος θεραπειας οξειας παραρρινοκολπιτιδαςInfo
- Publication number
- CY1110620T1 CY1110620T1 CY20101100378T CY101100378T CY1110620T1 CY 1110620 T1 CY1110620 T1 CY 1110620T1 CY 20101100378 T CY20101100378 T CY 20101100378T CY 101100378 T CY101100378 T CY 101100378T CY 1110620 T1 CY1110620 T1 CY 1110620T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pararrinokolpitidas
- acute
- treatment
- disease
- treating
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 230000001154 acute effect Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 229960002744 mometasone furoate Drugs 0.000 abstract 1
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 238000009097 single-agent therapy Methods 0.000 abstract 1
- 201000009890 sinusitis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Adhesives Or Adhesive Processes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53783004P | 2004-01-21 | 2004-01-21 | |
| EP05711867A EP1711164B1 (en) | 2004-01-21 | 2005-01-19 | Method of treating acute rhinosinusitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1110620T1 true CY1110620T1 (el) | 2015-04-29 |
Family
ID=34825945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20101100378T CY1110620T1 (el) | 2004-01-21 | 2010-04-28 | Μεθοδος θεραπειας οξειας παραρρινοκολπιτιδας |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20050186144A1 (https=) |
| EP (2) | EP1711164B1 (https=) |
| JP (2) | JP4976139B2 (https=) |
| AT (1) | ATE461693T1 (https=) |
| CA (1) | CA2554064A1 (https=) |
| CY (1) | CY1110620T1 (https=) |
| DE (1) | DE602005020113D1 (https=) |
| DK (1) | DK1711164T3 (https=) |
| ES (2) | ES2426957T3 (https=) |
| HR (1) | HRP20100208T8 (https=) |
| MX (1) | MXPA06008240A (https=) |
| PL (1) | PL1711164T3 (https=) |
| PT (1) | PT1711164E (https=) |
| RS (1) | RS51335B (https=) |
| SI (1) | SI1711164T1 (https=) |
| WO (1) | WO2005072704A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050186144A1 (en) * | 2004-01-21 | 2005-08-25 | Schering Corporation | Treatment methods |
| WO2008047149A1 (en) * | 2006-10-19 | 2008-04-24 | Cipla Limited | Pharmaceutical compositions and nasal spray incorporating anhydrous mometasone furoate |
| RU2407558C1 (ru) * | 2009-07-02 | 2010-12-27 | Федеральное государственное учреждение "Российский научный центр восстановительной медицины и курортологии Федерального агентства по здравоохранению и социальному развитию РФ" (ФГУ "РНЦВМиК Росздрава") | Способ лечения острого риносинусита у детей |
| TWI411121B (zh) * | 2010-03-11 | 2013-10-01 | Ind Tech Res Inst | 光吸收層之製造方法及應用其之太陽能電池結構 |
| US9744210B2 (en) | 2012-12-27 | 2017-08-29 | Massachusetts Eye & Ear Infirmary | Treatment of rhinosinusitis with P-glycoprotein inhibitors |
| WO2017123933A1 (en) | 2016-01-15 | 2017-07-20 | Massachusetts Eye And Ear Infirmary | Secreted p-glycoprotein is a non-invasive biomarker of chronic rhinosinusitis |
| WO2020198232A1 (en) | 2019-03-25 | 2020-10-01 | Massachusetts Eye And Ear Infirmary | Methods and compositions to treat and diagnose diseases or pathologies associated with inflammation of the sinuses and nasal cavity |
| IL299210A (en) * | 2020-06-21 | 2023-02-01 | Massachusetts Eye & Ear Infirmary | Combined treatment of verapamil and methotrexate for the treatment of chronic rhinosinusitis |
| JP2024049405A (ja) * | 2021-02-22 | 2024-04-10 | 興和株式会社 | 新規吸入剤 |
| EP4566595A1 (en) * | 2023-12-07 | 2025-06-11 | Bernhard Roth | Combination preparation for the treatment of acute and chronic rhinosinusitis |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CY1359A (en) | 1981-02-02 | 1987-08-07 | Schering Corp | Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them |
| US4731447A (en) | 1985-05-13 | 1988-03-15 | Schering Corporation | Process for preparing piperidylidene dihydro-dibenzo(a,d)-cycloheptenes or aza-derivatives thereof |
| US4873335A (en) | 1986-03-12 | 1989-10-10 | Schering Corporation | 3-phenethyl-2-benzene-amides or aza-derivatives thereof |
| CA2111002C (en) | 1991-06-10 | 2000-08-22 | Julianne Fassberg | Non-chlorofluorocarbon aerosol formulations |
| ATE339952T1 (de) * | 1991-06-10 | 2006-10-15 | Schering Corp | Fluorchlorkohlenwasserstofffreie aerosolformulierungen |
| US6127353A (en) | 1991-09-06 | 2000-10-03 | Schering Corporation | Mometasone furoate monohydrate, process for making same and pharmaceutical compositions |
| US5837699A (en) * | 1994-01-27 | 1998-11-17 | Schering Corporation | Use of mometasone furoate for treating upper airway passage diseases |
| PE44995A1 (es) * | 1994-01-27 | 1995-12-18 | Schering Corp | Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias |
| US6068832A (en) | 1996-08-29 | 2000-05-30 | Schering Corporation | Chlorofluorocarbon-free mometasone furoate aerosol formulations |
| US5837713A (en) * | 1997-02-26 | 1998-11-17 | Mayo Foundation For Medical Education And Research | Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids |
| US6495167B2 (en) * | 1997-03-20 | 2002-12-17 | Schering Corporation | Preparation of powder agglomerates |
| US6503537B2 (en) * | 1997-03-20 | 2003-01-07 | Schering Corporation | Preparation of powder agglomerates |
| US6187765B1 (en) | 1997-10-09 | 2001-02-13 | Schering Corporation | Mometasone furoate suspensions for nebulization |
| US6297227B1 (en) * | 1998-09-10 | 2001-10-02 | Schering Corporation | Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines |
| SE9803770D0 (sv) * | 1998-11-05 | 1998-11-05 | Astra Ab | Dry powder pharmaceutical formulation |
| US6465581B1 (en) * | 2001-01-24 | 2002-10-15 | The Goodyear Tire & Rubber Company | Silica reinforced rubber composition which contains stabilized unsymmetrical coupling agents and article of manufacture, including a tire, having at least one component comprised of such rubber composition |
| AR036358A1 (es) * | 2001-08-28 | 2004-09-01 | Schering Corp | Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma |
| ES2388537T3 (es) * | 2002-08-23 | 2012-10-16 | Merck Sharp & Dohme Corp. | Inhalador dosificador que contiene una formulación en suspensión de aerosol |
| US20040081625A1 (en) * | 2002-10-21 | 2004-04-29 | Schering Corporation | Nasal formulations for the treatment of allergies |
| US8912174B2 (en) * | 2003-04-16 | 2014-12-16 | Mylan Pharmaceuticals Inc. | Formulations and methods for treating rhinosinusitis |
| US20040235807A1 (en) * | 2003-05-21 | 2004-11-25 | Weinrich Karl P. | Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea |
| CN1870976A (zh) * | 2003-10-20 | 2006-11-29 | 先灵公司 | 药物组合物 |
| US20050186144A1 (en) * | 2004-01-21 | 2005-08-25 | Schering Corporation | Treatment methods |
| EP2651494B1 (en) | 2010-12-13 | 2017-02-15 | Pacesetter, Inc. | Delivery catheter |
| US9106249B1 (en) | 2014-09-04 | 2015-08-11 | Semtech Corporation | Calibration of a time-interleaved analog-to-digital converter |
-
2005
- 2005-01-19 US US11/038,343 patent/US20050186144A1/en not_active Abandoned
- 2005-01-19 WO PCT/US2005/002105 patent/WO2005072704A2/en not_active Ceased
- 2005-01-19 PL PL05711867T patent/PL1711164T3/pl unknown
- 2005-01-19 ES ES10003076T patent/ES2426957T3/es not_active Expired - Lifetime
- 2005-01-19 DE DE602005020113T patent/DE602005020113D1/de not_active Expired - Lifetime
- 2005-01-19 EP EP05711867A patent/EP1711164B1/en not_active Expired - Lifetime
- 2005-01-19 AT AT05711867T patent/ATE461693T1/de active
- 2005-01-19 RS RSP-2010/0236A patent/RS51335B/sr unknown
- 2005-01-19 JP JP2006551345A patent/JP4976139B2/ja not_active Expired - Fee Related
- 2005-01-19 CA CA002554064A patent/CA2554064A1/en not_active Abandoned
- 2005-01-19 ES ES05711867T patent/ES2340777T3/es not_active Expired - Lifetime
- 2005-01-19 EP EP10003076.6A patent/EP2201936B1/en not_active Revoked
- 2005-01-19 DK DK05711867.1T patent/DK1711164T3/da active
- 2005-01-19 HR HR20100208T patent/HRP20100208T8/xx unknown
- 2005-01-19 MX MXPA06008240A patent/MXPA06008240A/es active IP Right Grant
- 2005-01-19 PT PT05711867T patent/PT1711164E/pt unknown
- 2005-01-19 SI SI200531000T patent/SI1711164T1/sl unknown
-
2008
- 2008-01-28 JP JP2008016970A patent/JP2008110991A/ja active Pending
- 2008-07-11 US US12/171,989 patent/US20090022671A1/en not_active Abandoned
-
2010
- 2010-04-28 CY CY20101100378T patent/CY1110620T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK1711164T3 (da) | 2010-07-19 |
| US20090022671A1 (en) | 2009-01-22 |
| PT1711164E (pt) | 2010-06-28 |
| JP2007518817A (ja) | 2007-07-12 |
| HRP20100208T1 (hr) | 2010-05-31 |
| ATE461693T1 (de) | 2010-04-15 |
| MXPA06008240A (es) | 2006-08-31 |
| ES2340777T3 (es) | 2010-06-09 |
| EP1711164B1 (en) | 2010-03-24 |
| WO2005072704A2 (en) | 2005-08-11 |
| EP1711164A2 (en) | 2006-10-18 |
| EP2201936B1 (en) | 2013-06-19 |
| CA2554064A1 (en) | 2005-08-11 |
| DE602005020113D1 (de) | 2010-05-06 |
| SI1711164T1 (sl) | 2010-06-30 |
| EP2201936A1 (en) | 2010-06-30 |
| HRP20100208T8 (hr) | 2010-06-30 |
| RS51335B (sr) | 2011-02-28 |
| JP4976139B2 (ja) | 2012-07-18 |
| PL1711164T3 (pl) | 2010-09-30 |
| JP2008110991A (ja) | 2008-05-15 |
| US20050186144A1 (en) | 2005-08-25 |
| ES2426957T3 (es) | 2013-10-28 |
| WO2005072704A3 (en) | 2006-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110620T1 (el) | Μεθοδος θεραπειας οξειας παραρρινοκολπιτιδας | |
| HUS1500018I1 (hu) | A Bruton-féle tirozin-kináz inhibitorai | |
| WO2006078463A3 (en) | Method for treating cardiovascular disease | |
| EA201791669A2 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
| PT2420234E (pt) | 1h-benzimidazole-4-carboxamidas substituídas com um carbono quaternário na posição 2 como inibidores de parp para uso no tratamento do cancro | |
| LU92232I2 (fr) | "Florbétapir (18 F)" | |
| WO2007087468A3 (en) | Adiponectin for treatment of various disorders | |
| ATE530519T1 (de) | Cyclobutylaminderivate | |
| CY1112397T1 (el) | Συνδυασμενη θεραπεια για την αντιμετωπιση του καρκινου | |
| PT2383271E (pt) | Aminoquinolonas como inibidores de gsk-3 | |
| EA200401525A1 (ru) | Способы лечения гепатита (варианты ) | |
| PL2380584T3 (pl) | Sposób do immunostymulacji | |
| WO2006047631A3 (en) | Anti-mitotic anti-proliferative compounds | |
| CY1109666T1 (el) | Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας | |
| DK1715890T3 (da) | CTGF som mål for mikroalbuminuriterapi hos patienter med diabetisk nefropati | |
| TW200740441A (en) | Methods and reagents for the treatment of inflammatory disorders | |
| WO2008019388A3 (en) | Milnacipran for the treatment of fatigue associated with fibromyalgia syndrome | |
| WO2006078713A3 (en) | Methotrexate combinations for treating inflammatory diseases | |
| ATE527997T1 (de) | Verwendung von aminapthon zur herstellung eines medikaments zur behandlung von arteriopathien | |
| BRPI0503827A (pt) | métodos para prevenir ou tratar infecções respiratórias em lactentes | |
| WO2008016665A3 (en) | Imidazoacridine compounds for treating flt3 -mediated disorders | |
| RU2007103667A (ru) | Способ лечения псориаза | |
| DK1732648T3 (da) | Sygdomsbehandling | |
| WO2007017652A3 (en) | Arylakylamines for the treatment of cancer | |
| WO2008036157A3 (en) | Prophylactic and therapeutic treatment of avian influenza infections in animals |